This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by DBV Technologies.
Reference
Shaker M, et al. Commercial Claims Costs Related to Healthcare Resource Use Associated With a Diagnosis of Peanut Allergy. Annals of Allergy, Asthma and Immunology : 16 Jan 2020. Available from: URL: http://doi.org/10.1016/j.anai.2020.01.004
Rights and permissions
About this article
Cite this article
Peanut allergy: substantial disease burden in the US. PharmacoEcon Outcomes News 846, 20 (2020). https://doi.org/10.1007/s40274-020-6559-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6559-1